IBJI
Contact Us Today!
Please fill out the form below and an IBJI Representative will contact you.

Asterisk (*) Indicates Required Field

Name*:

Phone Number*:
   

Email*:

Preferred Contact:

Email
Phone

Are you a current patient?*
 Yes  No

Location:

Reason for Visit:

Interpreter available upon request.

Patient information is kept strictly private.

To add details about your visit, please use our secure form.

PDF Print E-mail

Current Rheumatoid Arthritis Studies at IBJI

Just discovered you have Rheumatoid Arthritis?

If you have early rheumatoid arthritis, you may be interested in learning about the Function Study. This clinical research study will evaluate the effects of an investigational medication on early rheumatoid arthritis.

You may be eligible for the Function Study if you:

  • Are aged 18 years or older
  • Have had rheumatoid arthritis for less than 2 years
  • Have never taken a medication called methotrexate

Participants will receive all study medications and study-related medical supervision at no charge during the study.

To find out more about this opportunity to participate in clinical research, please call us or complete the contact form and reference the RAFN study.

Do you have Rheumatoid Arthritis?

If you have rheumatoid arthritis, you may be interested in learning about the Summacta Study. This clinical research study will evaluate an investigational self-injectable form of an approved rheumatoid arthritis (RA) treatment that is currently only available intravenously.

If proven safe and effective, the new formulation will offer RA patients the freedom and flexibility to take RA medicine at their own convenience.

You may be eligible for the Summacta Study if you:

  • Are affected by moderate to severe active RA
  • Have an inadequate response to current therapy

If you choose to take part in the study, all study drug and all study procedures will be provided throughout the study at no cost to you.

To find out more about this opportunity to participate in clinical research, please call us or complete the contact form and reference the RASU study. Thank you.